Please login to the form below
medicines value
This page shows the latest medicines value news and features for those working in and with pharma, biotech and healthcare.
Novartis sells off part of Sandoz portfolio
Francis adds: “Sharpening our portfolio focus in the US allows us to devote more time and resources toward our strategy of bringing complex generics, value-added medicines and biosimilars to patients, ... creating higher value and opening up access to
Latest news
-
Your excellent marketing team
From working co-operatively with healthcare professionals to supporting their educational needs, and from launching new medicines to creating added value services, PMEA aims to provide a channel for our ... Those who win also see the value that external
-
Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate
2018. NHS England says its ambition is for the NHS to achieve a recurrent annual saving of £200-300m by 2021 through the increased use of best value biological medicines. ... It says it has already achieved £210m savings from the use of biosimilar
-
NHS England to Vertex: come clean on Orkambi offer
Vertex has responded coolly to the new offer – which comes after almost two years of negotiations – saying it believes it still doesn’t reflect the value of the therapies but adding ... that the company “stands ready to meet to find a productive
-
Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
The plan includes a wide range of proposals, including eliminating some rebates that are paid to pharmacy benefit managers, emphasizing so-called value-based contracts, and switching some medicines from Part
-
Novartis follows Pfizer and freezes US prices this year
CEO Vas Narasimhan – just 100 days into the role – told CNBC that “our goal is always to price our medicines with a value-based approach where we can … be reasonable with ... We made significant progress this quarter to transform Novartis into a
More from news
Approximately 2 fully matching, plus 131 partially matching documents found.
Latest Intelligence
-
30 Women Leaders in UK Healthcare
world value of its medicines. ... 6. Dr Susan Galbraith, Senior VP and Head of Oncology at AstraZeneca’s Innovative Medicines and Early Development (IMED) Biotech Unit.
-
Working with our healthcare system more closely is vital
The new scheme needs to be balanced to ensure that patients get the new medicines they need; deliver value for money for the NHS; and enable a thriving UK pharmaceutical sector ... that can continue to innovate in medicines and create jobs and value to
-
Adding value in emerging markets
Branded generics offer something of value. When you think of generic medicines, you think low cost, high volume, little differentiation. ... Well, there are a number of ways to add value to off-patent medicines.
-
Biosimilars: what the future looks like
itself. We must build on the experience gained over the years of development and identify new opportunities where these medicines can truly add value. ... This also marked the culmination of many years of commitment and people’s personal journeys to
-
Righting pharma’s reputational wrongs
People say we have a powerful story to tell about the value of our medicines but are poor at getting the message across. ... These relationships are incredibly important and play a vital role in the development and delivery of new medicines.
More from intelligence
Approximately 1 fully matching, plus 36 partially matching documents found.
Latest appointments
-
Redx poaches AstraZeneca senior executive
grow this company into a very excising and meaningful entity that has the potential to create both important new medicines for patients and generate significant value for shareholders.".
-
Sanofi appoints Dr Yong-Jun Liu as head of research
In his new role, Dr Liu will be responsible for all of the Paris-based pharmaceutical company's research and will be tasked with delivering innovative and high-value medicines.
-
ABPI Scotland appoints Sandra Auld as director
the access to and use of new and innovative medicines for Scottish patients. “ ... The ABPI Scotland team is fully committed to working with all of our stakeholders to support a common understanding and appreciation of the life-saving and
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
How to measure health behaviour change programmes
The value outcome of medicines is still largely measured against healthcare systems or general societal outcomes. ... But the ways in which we measure patient benefits and value needs to be equally creative.
-
How will the NHS’s new medicines savings drive affect pharma?
value medicines that can be easily bought over-the-counter, such as antihistamines and sun cream. ... In conclusion, the need for pharma to prove the value of its products has never been greater.
-
Packer Forbes collaborates with NHS Expert to strengthen growing team
With today’ s emphasis on economic as well as clinical value, it recognises access barriers to medicines as a key challenge and works to uncover insightful understanding of the issues in
-
Value of Medicines
Value of Medicines. By focusing on cost are we obscuring the true value of medicines? ... David Coleiro, Paula Lashley and John Grime take a look at how society values medicines, the role of health technology assessment (HTA) bodies like NICE, what value
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
-
Senior Medical Writer
-
Salary is DOE
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
-
Associate Scientific Director
-
Salary TBC
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Sudler London - Senior Medical Writer
-
Competitive
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Account Manager
-
Negotiable
Subscribe to our email news alerts
- Tox trouble stalls Sosei/Allergan Alzheimer’s drug
- London cancer hub launched by Cancer Research UK
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Making a Difference - The Future of Pharma
- AZ prepares to file COPD triple, taking on rival GSK
- Controversy grows around GP at Hand service after minister’s endorsement
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
